Table 1A. Characteristics of 547 N2–3 NPC patients stratified by adjuvant chemotherapy.
| N2–3 (n = 547) | |||
|---|---|---|---|
| non-AC group (%) (n = 341) | AC group (%) (n = 206) | P | |
| Age | 0.097 | ||
| Median (yrs) | 46 | 48 | |
| Range (yrs) | 7–75 | 15–70 | |
| Sex | 0.660 | ||
| Male | 254 (74.5) | 158 (76.7) | |
| Female | 87 (25.5) | 48 (23.3) | |
| KPS score | 0.294 | ||
| 80–100 | 338 (99.1) | 206 (100.0) | |
| 60–70 | 3 (0.9) | 0 (0.0) | |
| T stage | 0.204 | ||
| T1 | 79 (23.2) | 40 (19.4) | |
| T2A/2B | 134 (39.3) | 91 (44.2) | |
| T3 | 95 (27.8) | 47 (22.8) | |
| T4 | 33 (9.7) | 28 (13.6) | |
| AJCC stage | 0.005* | ||
| III | 240 (70.4) | 118 (57.3) | |
| IVa | 29 (8.5) | 20 (9.7) | |
| IVb | 72 (21.1) | 68 (33.0) | |
| RT dose | 0.305 | ||
| Median (Gy) | 66 | 66 | |
| Range (Gy) | 63.8–77.3 | 60–74.8 | |
*
indicated p < 0.05.